Fortress Biotech, Inc. (NASDAQ:FBIOP) Short Interest Update

Fortress Biotech, Inc. (NASDAQ:FBIOP) was the target of a large growth in short interest in September. As of September 30th, there was short interest totalling 2,200 shares, a growth of 144.4% from the September 15th total of 900 shares. Based on an average daily trading volume, of 24,500 shares, the short-interest ratio is presently 0.1 days.

Fortress Biotech Trading Up 1.9 %

Shares of NASDAQ FBIOP traded up $0.09 during midday trading on Friday, hitting $5.14. 13,882 shares of the stock traded hands, compared to its average volume of 17,023. Fortress Biotech has a one year low of $4.86 and a one year high of $18.00. The business has a 50 day moving average price of $6.07 and a two-hundred day moving average price of $11.44.

Fortress Biotech Company Profile

Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet.